Tag:

emerging markets

Latest Headlines

Latest Headlines

TPP deadlocked on biologics with Japan and U.S. standing fast

The latest round of meetings by the dozen Trans-Pacific Partnership nations once again failed to come up with a solution for the dispute between developed countries and emerging markets over the length of pharmaceutical patents, particularly for biologics.

FDA grants emergency use authorization to Corgenix's fast-acting Ebola diagnostic

"This thing isn't over yet," warned President Barack Obama's Ebola czar Ron Klain in a recent interview. While recovering slowly West Africa is plagued by the epidemic and needs new tools in the ongoing battle against the disease.

UPDATE: Takeda confirms eyeing opportunities in India, elsewhere, in vaccine space

Japan's Takeda Pharmaceutical has looked at Indian companies in the vaccine space as it moves to tighten focus on that aspect of its business ahead of a Phase III trial for a dengue candidate and more broadly emerging markets as seen by a recent M&A deal in Turkey.

From the pharma C-suite: Notable, quotable remarks on Asia, emerging markets (Part 2)

Here is part two of comments from C-suite execs on emerging markets and Asia in the latest quarterly conference calls.

From the pharma C-suite: Notable, quotable remarks on Asia, emerging markets

FiercePharma brings you notes on the Asian and emerging markets operations of major drug companies from fourth-quarter earnings calls to explain what C-suite executives are focused on.

Abbott tests the power of a Big Pharma name with international branding push

With growing competition in emerging markets, Abbott wants to make sure its products stay in the forefront. So, it's rolling out a new branding campaign to cozy up with consumers and amp up its international name recognition.

Cipla buys capacity in Yemen with deal to control company there

India-based Cipla has been expanding its manufacturing footprint outside of its base in India and has now made the jump across the Arabian Sea to Yemen.

Danaher demurs on M&A, looks to China, Brazil and Russia

Diversified conglomerate Danaher emphasized organic growth rather than acquisitions at a recent investor meeting. That's despite much speculation on its M&A appetite following the Medtronic announcement that it will acquire Covidien.

Pharma sales force took a hit in North America and Europe in 2013, new report shows

Amid new layoffs and plummeting revenues, the pharma sales force continued to decline in North America and Europe in 2013.

GE rolls out a discount cancer imaging system for personalized medicine in India

GE Healthcare has developed a discount molecular imaging system for cancer detection, intended for physicians practicing personalized medicine in emerging markets--especially India, where the devicemaker got help designing the system.